DGAP-News: Lifestyle Delivery Systems Inc. Announces Commencement of Nursery Operations at Core Isogenics Inc.

Nachricht vom 06.02.201906.02.2019 (www.4investors.de) -


DGAP-News: Lifestyle Delivery Systems Inc. / Key word(s): Product Launch/Market launch

Lifestyle Delivery Systems Inc. Announces Commencement of Nursery Operations at Core Isogenics Inc.
06.02.2019 / 14:15


The issuer is solely responsible for the content of this announcement.
Lifestyle Delivery Systems Inc. Announces Commencement of Nursery Operations at Core Isogenics Inc.

Vancouver, British Columbia, Canada, February 6, 2019, Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc. ("Core Isogenics") has begun nursery operations at the Adelanto facility.

Core Isogenics has begun operations in cannabis plant genetic development. The goal is to control all aspects of plant genetics with consistent and repeatable cannabinoid, terpene and flavonoid profile compositions. The success of this process will result in product consistency that is unmatched in the industry. The plants that will be developed by Core Isogenics will have defined yields and precise genetic profiles for Core Isogenics' cultivation as well as contract growers.

The Core Isogenics nursery will develop its plant genetics technology and produce seeds with identical properties to the formulas required for multiple versions of CannaStripsTM, thereby reducing the number of extraction steps currently required to extract ingredients from more than one plant to a single plant extraction with the exact ingredients already in its DNA. The Core Isogenics seeds will be germinated inside of Core Isogenics' climate-controlled, negatively-pressurized, and remotely-monitored rooms to ensure contaminant-free plant development. The seedlings from the nursery will be transported to Core Isogenics' automated cultivation environment which will maximize plant growth and shorten grow cycle.

Core Isogenics has eight defined isogenic climate-controlled, negatively-pressurized, and remotely-monitored rooms for the improvement of current strains and four identical rooms for experimental strains. The Company anticipates an annual production of over three million isogenic seeds. These isogenic strains will be developed for both indoor and outdoor cultivation with a focus on future large outdoor farms.

Lifestyle Delivery Systems Inc.'s CEO, Brad Eckenweiler, stated, "The medicinal future of cannabis depends on the ability of cultivators and manufacturers to deliver the same exacting ingredients consistently. That is only possible if those ingredients can be repeated harvest after harvest, which can be achieved only through the complete control of the cannabis plant genetics. Currently the cannabis market is a menagerie of cross strains constantly splicing and cloning creating weaker and weaker genetics in search of THC, which has resulted in the need for many cultivators to use herbicides, fungicides and pesticides. We believe our approach can change the direction of cannabis cultivation for the better. Fifty years ago this plant grew wild without chemicals or human intervention and we will develop that plant again through our genetic pollination program, without cloning or GMO technology." Mr. Eckenweiler went on to say, "By the way, we just witnessed our first generation of seeds popping into the cannabis world. The Company is confident that the Core Isogenics technology and the resulting isogenic strains will benefit the entire cannabis industry."Seedlings in the Core Isogenics' environmentally controlled nursery
The Company will continue its development of processes and product lines as well as building its distribution network.

About Core Isogenics Inc. Core Isogenics Inc. is located in Adelanto, California and is a City permitted and State Licensed cultivation and nursery operation in the California cannabis industry. Developing isogenic seed strains and automated cultivation methods for the cannabis industry with Lifestyle Delivery Systems Inc., a British Columbian company.About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a
state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.

Lifestyle Delivery Systems Inc.
Brad Eckenweiler
CEO & Director
Lifestyle Delivery Systems Inc.

Suite 820, 1130 W. Pender St.
Vancouver BC, V6E 4A4
T: +1 (866) 347-5058 F: +1 (604) 648-0517

CSE : LDS

OTCQB : LDSYF

Frankfurt: LD6, WKN: A14XHT

www.lifestyledeliverysystem.com

FOR MORE INFORMATION, PLEASE CONTACT:information@CSPAGroup.comCautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.












06.02.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de



772985  06.02.2019 







Aktuelle Nachrichten aus der 4investors-Redaktion

21.02.2019 - Mologen Aktie: Kommt nun die zweite Welle von Gewinnmitnahmen?
21.02.2019 - Wirecard Aktie: Kommt noch ein Absturz?
21.02.2019 - Dermapharm bringt neue Heuschnupfen-Arzneien auf den Markt
21.02.2019 - RIB Software übernimmt Mehrheit an Levtech
21.02.2019 - Datron hält Dividende konstant - Gewinnanstieg erwartet
21.02.2019 - Datagroup: „Auftragseingang in den vergangenen Monaten war sensationell”
21.02.2019 - Siltronic Aktie stürzt ab - Ausblick verschreckt die Börse
21.02.2019 - Deutsche Telekom hebt Dividende an: In den USA läuft es
21.02.2019 - Henkel erhöht die Dividende - Gewinnrückgang erwartet
21.02.2019 - Nordex: Börse hakt Gewinneinbruch schnell ab - Kaufsignal!


Chartanalysen

21.02.2019 - Mologen Aktie: Kommt nun die zweite Welle von Gewinnmitnahmen?
21.02.2019 - Wirecard Aktie: Kommt noch ein Absturz?
21.02.2019 - Geely Aktie: Ein Grund zur Sorge
21.02.2019 - Nel Aktie: Gehen die Bullen jetzt hart ins Risiko?
21.02.2019 - Deutsche Bank Aktie: Was jetzt wichtig ist…
21.02.2019 - Steinhoff Aktie: Noch mehr Stress mit Aktionären?
20.02.2019 - Mologen Aktie: Ist die Kursparty gleich vorbei?
20.02.2019 - Commerzbank Aktie: Ein positives Zeichen, aber…
20.02.2019 - Nel Aktie: Die Absturzgefahren werden nicht kleiner
20.02.2019 - TUI Aktie: Schwierigkeiten beim Comebackversuch


Analystenschätzungen

21.02.2019 - Deutsche Telekom: Prognose für 2020 steigt an
21.02.2019 - Glencore: Komplizierte Gemengelage
21.02.2019 - Henkel: Investitionen drücken Marge
21.02.2019 - Fresenius Medical Care: Gewinnerwartungen steigen an
21.02.2019 - Aixtron Aktie: Das belastet den Aktienkurs
20.02.2019 - ElringKlinger Aktie: Die Quittung für den Dividenden-Ausfall
20.02.2019 - Fresenius kommt an der Börse gut an - Kaufempfehlungen
20.02.2019 - Telefonica Deutschland: Erste Reaktionen auf die Zahlen für 2018
20.02.2019 - Deutsche Telekom Aktie: Wird das noch was?
19.02.2019 - Mensch und Maschine: Kaufempfehlung für die Aktie


Kolumnen

21.02.2019 - Adidas Aktie: Gelingt der Befreiungsschlag? - UBS Kolumne
21.02.2019 - DAX: Die Bullen sind am Drücker - UBS Kolumne
21.02.2019 - Nikkei 225-Index gewinnt seit Jahresbeginn rund 7 Prozent - Commerzbank Kolumne
21.02.2019 - DAX: Fokus auf 11.570 - bis dahin ist es aber noch ein gutes Stück - Donner & Reuschel Kolumne
20.02.2019 - Trend läuft weiter gegen den Euro - Donner & Reuschel Kolumne
20.02.2019 - DAX: Bekommen die Käufer nun kalte Füße? - UBS Kolumne
20.02.2019 - EuroStoxx 50: Markante Widerstandszone voraus - UBS Kolumne
20.02.2019 - Nachlassende Nachfragedynamik belastet Rohstoffpreise, langfristig Angebotslücke? - Commerzbank Kolumne
20.02.2019 - DAX lächelt freundlich, Bodenbildung aber keine Euphorie - Donner & Reuschel Kolumne
19.02.2019 - Deutschland: ZEW-Konjunkturerwartungen für den Februar - VP Bank Kolumne

All Right Reserved by minimalthemes - ©2018 Stoffels & Barck GbR